Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

PVR Index

Critical Unit Alert

Correct units: PVRI is expressed in WU·m² (Wood Units × meters squared). A systematic review (Kwan et al., 2019) found over 50% of literature uses incorrect units (like WU/m²), which can lead to clinical misinterpretation and dosing errors.

Hemodynamic Inputs

Normal Range (WU·m²)

  • Normal< 3.0
  • Elevated3.0 – 6.0
  • Severe> 6.0

Clinical Precision

Standardization to Body Surface Area (BSA) is critical in assessing pulmonary vascular remodeling. PVRI values are less sensitive to body habitus changes than absolute PVR, making it the preferred metric for transplant listing and complex PAH management.

Evidence-Based Hematology Protocol

Reference: Benza RL, et al. Predicting Survival in PAH: REVEAL Risk Score 2.0. Chest. 2019.

Normal thresholds per 2026 ESC/ERS Guidelines for Pulmonary Hypertension.

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Primary Clinical Uses

Assessment of pulmonary vascular disease severity in pulmonary arterial hypertension (PAH)
Determining candidacy for ASD/VSD closure (PVRI >3 WU·m² is a relative contraindication)
Cardiac transplantation evaluation (PVRI >6 WU·m² is a relative contraindication per ISHLT)
Liver transplantation risk stratification (portopulmonary hypertension)
Perioperative hemodynamic monitoring in cardiac surgery
Guiding vasodilator therapy in critically ill patients

Why Indexing Matters

PVRI normalizes absolute PVR to body surface area (BSA). This accounts for varying body size, especially important in pediatric patients and adults with extremes of BSA. A systematic review by Kwan et al. (2019) found that 54.6% of published literature uses incorrect units (e.g., WU/m² instead of WU·m²), leading to potential clinical errors.

How it Works

Formula

PVRI = (mPAP − PAWP) / CI Where: • mPAP = mean pulmonary artery pressure (mmHg) • PAWP = pulmonary artery wedge pressure (mmHg) • CI = cardiac index (L/min/m²) Units: PVRI is expressed in Wood Units · m² (WU·m²) Alternative unit conversion: 1 WU·m² = 80 dynes·sec·cm⁻⁵·m²

Derivation (Ohm’s Law Analog)

PVR = (mPAP − PAWP) / Qp, where Qp = cardiac output (L/min). Indexing divides by BSA: CI = Qp / BSA. Therefore PVRI = (ΔP) / CI. Because CI is in denominator, BSA moves to numerator, giving final units of pressure × time × BSA → WU·m².

Critical Unit Alert

⚠️ INCORRECT: WU/m², WU·m⁻², or dynes·sec·cm⁻⁵·m⁻². These units mathematically invert the BSA correction and will misclassify patients. CORRECT: WU·m² (Wood Units × meters squared).

Reference Values & Thresholds

CategoryPVRI (WU·m²)Clinical Implication
Normal< 3Normal pulmonary vascular resistance. Low risk for adverse outcomes.
Elevated (Mild-Moderate)3 – 6Pulmonary hypertension. Consider vasodilator testing.
Severe Elevation> 6High risk for right heart failure. Relative contraindication for cardiac transplantation (ISHLT).
Prohibitive (ASD/VSD closure)> 3AHA/ATS 2015 guidelines advise against defect closure if PVRI >3 WU·m² and PVR index >6 WU·m² post-vasodilator.

Clinical Pearls

Measurement Pitfalls

PAWP must be measured at end‑expiration (avoid respiratory variation artifacts)
If PAWP unobtainable, mean left atrial pressure or LVEDP may be substituted (LVEDP is 2-3 mmHg higher)
Thermodilution CI may be inaccurate with right-to-left shunts or severe tricuspid regurgitation – use Fick method with measured VO₂
Estimated VO₂ (using formulae) introduces significant error – measured VO₂ is preferred
In atrial fibrillation, average 5-10 beats for pressures and CI

Key Evidence from Kwan et al. 2019

Systematic review of 218 articles using “PVRI” in PubMed (1980‑2018)
33 unique unit variations identified
Only 45.4% of articles used correct units (WU·m² or dynes·sec·cm⁻⁵·m²)
Pediatric literature performed better: 62.2% correct vs 41.0% in non‑pediatric
Consequences: misdiagnosis of operability for ASD/VSD closure, inappropriate transplant listing

Clinical Example of Unit Error

Patient: BSA 2.0 m², PVR = 2 WU → Correct PVRI = 4 WU·m². If incorrectly reported as WU/m², the value becomes 1 WU/m² (4× lower). This underdiagnosis could lead to inappropriate ASD/VSD closure with fatal pulmonary hypertensive crisis.

Next Steps

Clinical Actions by PVRI Range

01
PVRI < 3 WU·m²: Normal. No specific intervention needed for pulmonary vasculature.
02
PVRI 3‑6 WU·m²: Evaluate for WHO Group 1 PAH or Group 2 left heart disease. Consider vasodilator challenge (inhaled nitric oxide or IV adenosine). If reversible (>20% decrease), may consider calcium channel blockers.
03
PVRI > 6 WU·m²: High risk. Escalate PAH therapy (prostacyclin analogs, endothelin antagonists). For transplant candidates, reassess after pulmonary vasodilator therapy.
04
ASD/VSD closure: AHA/ATS 2015 guidelines recommend against closure if baseline PVRI > 3 WU·m² and PVR index > 6 WU·m² after vasodilator testing.

Transplant Listing Criteria (ISHLT 2006)

Relative contraindications: PVR > 5 WU or PVRI > 6 WU·m² that is unresponsive to vasodilator testing (defined as failure to decrease to < 2.5 WU or < 3.0 WU·m²). Absolute contraindication: Transpulmonary gradient > 15 mmHg and PVRI > 6 WU·m² with systolic pulmonary artery pressure > 60 mmHg.

The Evidence

Primary Reference – Unit Standardization (Clickable)

Pulmonary vascular resistance index: Getting the units right and why it matters

Kwan WC et al. • Clinical Cardiology. 2019;Comprehensive review of PVRI unit confusion across 218 publications. Documents that 54.6% of literature uses incorrect units, with potentially life‑altering consequences.

View Source

Guideline References (Clickable)

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Galiè N et al. • European Respiratory Journal. 2015;Defines diagnostic thresholds for PAH including PVRI criteria.

View Source
2015 AHA/ATS Guidelines for Pediatric Pulmonary Hypertension

Abman S et al. • Circulation. 2015;Establishes PVRI > 3 WU·m² as threshold for defining PAH in children and contraindication for ASD/VSD closure.

View Source
Listing Criteria for Heart Transplantation: ISHLT Guidelines

Mehra MR et al. • Journal of Heart and Lung Transplantation. 2006;Defines PVRI > 6 WU·m² as relative contraindication for cardiac transplantation.

View Source

Origins & History

Historical Derivation

PVRI was introduced by pediatric cardiologists in the 1970s to account for body size when assessing operability of congenital heart defects. The indexing corrects for the proportional relationship between body surface area and pulmonary blood flow. The formula applies Ohm’s law (R = ΔP / Q) to the pulmonary circulation, with flow indexed to BSA. Despite decades of use, unit confusion persists, prompting the Kwan et al. 2019 call for standardization.

Last Comprehensive Review: 2026-07-17

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Primary Clinical Uses

Assessment of pulmonary vascular disease severity in pulmonary arterial hypertension (PAH)
Determining candidacy for ASD/VSD closure (PVRI >3 WU·m² is a relative contraindication)
Cardiac transplantation evaluation (PVRI >6 WU·m² is a relative contraindication per ISHLT)
Liver transplantation risk stratification (portopulmonary hypertension)
Perioperative hemodynamic monitoring in cardiac surgery
Guiding vasodilator therapy in critically ill patients

Why Indexing Matters

PVRI normalizes absolute PVR to body surface area (BSA). This accounts for varying body size, especially important in pediatric patients and adults with extremes of BSA. A systematic review by Kwan et al. (2019) found that 54.6% of published literature uses incorrect units (e.g., WU/m² instead of WU·m²), leading to potential clinical errors.

How it Works

Formula

PVRI = (mPAP − PAWP) / CI Where: • mPAP = mean pulmonary artery pressure (mmHg) • PAWP = pulmonary artery wedge pressure (mmHg) • CI = cardiac index (L/min/m²) Units: PVRI is expressed in Wood Units · m² (WU·m²) Alternative unit conversion: 1 WU·m² = 80 dynes·sec·cm⁻⁵·m²

Derivation (Ohm’s Law Analog)

PVR = (mPAP − PAWP) / Qp, where Qp = cardiac output (L/min). Indexing divides by BSA: CI = Qp / BSA. Therefore PVRI = (ΔP) / CI. Because CI is in denominator, BSA moves to numerator, giving final units of pressure × time × BSA → WU·m².

Critical Unit Alert

⚠️ INCORRECT: WU/m², WU·m⁻², or dynes·sec·cm⁻⁵·m⁻². These units mathematically invert the BSA correction and will misclassify patients. CORRECT: WU·m² (Wood Units × meters squared).

Reference Values & Thresholds

CategoryPVRI (WU·m²)Clinical Implication
Normal< 3Normal pulmonary vascular resistance. Low risk for adverse outcomes.
Elevated (Mild-Moderate)3 – 6Pulmonary hypertension. Consider vasodilator testing.
Severe Elevation> 6High risk for right heart failure. Relative contraindication for cardiac transplantation (ISHLT).
Prohibitive (ASD/VSD closure)> 3AHA/ATS 2015 guidelines advise against defect closure if PVRI >3 WU·m² and PVR index >6 WU·m² post-vasodilator.

Clinical Pearls

Measurement Pitfalls

PAWP must be measured at end‑expiration (avoid respiratory variation artifacts)
If PAWP unobtainable, mean left atrial pressure or LVEDP may be substituted (LVEDP is 2-3 mmHg higher)
Thermodilution CI may be inaccurate with right-to-left shunts or severe tricuspid regurgitation – use Fick method with measured VO₂
Estimated VO₂ (using formulae) introduces significant error – measured VO₂ is preferred
In atrial fibrillation, average 5-10 beats for pressures and CI

Key Evidence from Kwan et al. 2019

Systematic review of 218 articles using “PVRI” in PubMed (1980‑2018)
33 unique unit variations identified
Only 45.4% of articles used correct units (WU·m² or dynes·sec·cm⁻⁵·m²)
Pediatric literature performed better: 62.2% correct vs 41.0% in non‑pediatric
Consequences: misdiagnosis of operability for ASD/VSD closure, inappropriate transplant listing

Clinical Example of Unit Error

Patient: BSA 2.0 m², PVR = 2 WU → Correct PVRI = 4 WU·m². If incorrectly reported as WU/m², the value becomes 1 WU/m² (4× lower). This underdiagnosis could lead to inappropriate ASD/VSD closure with fatal pulmonary hypertensive crisis.

Next Steps

Clinical Actions by PVRI Range

01
PVRI < 3 WU·m²: Normal. No specific intervention needed for pulmonary vasculature.
02
PVRI 3‑6 WU·m²: Evaluate for WHO Group 1 PAH or Group 2 left heart disease. Consider vasodilator challenge (inhaled nitric oxide or IV adenosine). If reversible (>20% decrease), may consider calcium channel blockers.
03
PVRI > 6 WU·m²: High risk. Escalate PAH therapy (prostacyclin analogs, endothelin antagonists). For transplant candidates, reassess after pulmonary vasodilator therapy.
04
ASD/VSD closure: AHA/ATS 2015 guidelines recommend against closure if baseline PVRI > 3 WU·m² and PVR index > 6 WU·m² after vasodilator testing.

Transplant Listing Criteria (ISHLT 2006)

Relative contraindications: PVR > 5 WU or PVRI > 6 WU·m² that is unresponsive to vasodilator testing (defined as failure to decrease to < 2.5 WU or < 3.0 WU·m²). Absolute contraindication: Transpulmonary gradient > 15 mmHg and PVRI > 6 WU·m² with systolic pulmonary artery pressure > 60 mmHg.

The Evidence

Primary Reference – Unit Standardization (Clickable)

Pulmonary vascular resistance index: Getting the units right and why it matters

Kwan WC et al. • Clinical Cardiology. 2019;Comprehensive review of PVRI unit confusion across 218 publications. Documents that 54.6% of literature uses incorrect units, with potentially life‑altering consequences.

View Source

Guideline References (Clickable)

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Galiè N et al. • European Respiratory Journal. 2015;Defines diagnostic thresholds for PAH including PVRI criteria.

View Source
2015 AHA/ATS Guidelines for Pediatric Pulmonary Hypertension

Abman S et al. • Circulation. 2015;Establishes PVRI > 3 WU·m² as threshold for defining PAH in children and contraindication for ASD/VSD closure.

View Source
Listing Criteria for Heart Transplantation: ISHLT Guidelines

Mehra MR et al. • Journal of Heart and Lung Transplantation. 2006;Defines PVRI > 6 WU·m² as relative contraindication for cardiac transplantation.

View Source

Origins & History

Historical Derivation

PVRI was introduced by pediatric cardiologists in the 1970s to account for body size when assessing operability of congenital heart defects. The indexing corrects for the proportional relationship between body surface area and pulmonary blood flow. The formula applies Ohm’s law (R = ΔP / Q) to the pulmonary circulation, with flow indexed to BSA. Despite decades of use, unit confusion persists, prompting the Kwan et al. 2019 call for standardization.

Last Comprehensive Review: 2026-07-17

Recent Journal Updates

JAMAJul 21, 2026
Correction to Primary Composite Outcome in a Trial of Transfusion Strategy

Clinical Context

We think this might be relevant to the clinical guidance for Pulmonary Vascular Resistance Index (PVRI).

FDA MedWatchJul 20, 2026
Early Alert: Intravascular Administration Set Issue from Baxter

Clinical Context

We think this might be relevant to the clinical guidance for Pulmonary Vascular Resistance Index (PVRI).

FDA MedWatchJul 13, 2026
Pulmonary Valve Catheter Delivery System Recall: Medtronic Removes Harmony Delivery Catheter System (DCS)

Clinical Context

We think this might be relevant to the clinical guidance for Pulmonary Vascular Resistance Index (PVRI).